The consistent growth
Growth Debt Pioneer
Since 1998, Kreos Capital has committed in excess of €5.7bn across +750 transactions, to more than 570 pan-European and Israeli high-growth companies in the technology and healthcare sectors. Today, we invest more than €800m a year and continue to enhance our product offering and presence in the market.
Throughout this time, Kreos Capital has been the consistent growth partner of choice, providing clarity and continuity for both management teams and equity sponsors looking for a long-term finance partner.
Flexible, tailored approach
At Kreos Capital, we understand that true innovation requires adaptable and responsive financing. With significant financial backing from blue-chip institutional investors, robust infrastructure, and large, experienced investment team, Kreos consistently provides debt facilities that match the ever evolving needs of high-growth companies.
Support for every stage
Kreos Capital has the experience and resources to support high-growth companies through every stage of their growth life cycle, from entry-level growth, mid-stage development, through to late stage & pre-IPO / exit funding, as well as publicly listed growth funding.
Extensive experience & investment history in Technology & Healthcare
Kreos Capital provides financing for companies across the wide spectrum of the Technology and Healthcare sectors. In Technology, we have invested across fintech, enterprise software, cybersecurity, semiconductors, digital marketing, AI and other sub-sectors, while in Healthcare, we have backed companies in areas such as drug & treatment development, medical products & devices, and healthcare tech.
Successful track record
Kreos Capital has built its reputation through an unwavering support for all of our portfolio companies during multiple business cycles. We rely on our close and mutually beneficial working relationships with both our equity sponsor partners and management teams, and they can rely on us to successfully navigate through every stage of the economic cycle. That is why we are widely recognised throughout the industry as the preferred choice when partners are really needed.